IPL344

( DrugBank: IPL-344 / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	2

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03755167 (ClinicalTrials.gov)	December 9, 2018	21/11/2018	A Follow up Study to Protocol 101/2 - Continued Treatment by IPL344 IV	An Open-Label, Multi-Center, Follow up Study to Protocol 101/2 - Continued Treatment by Intravenousl ...	Amyotrophic Lateral Sclerosis (ALS)	Drug: IPL344	Immunity Pharma Ltd.	NULL	Recruiting	18 Years	75 Years	All	15	Phase 2	Israel
2	NCT03652805 (ClinicalTrials.gov)	August 1, 2018	13/8/2018	A Study of IPL344 in the Treatment of ALS Patients	Phase 1/2a, Multi-center, Open-Label, Dose-escalating Study to Assess Safety, Tolerability, and Phar ...	Amyotrophic Lateral Sclerosis	Drug: IPL344	Immunity Pharma Ltd.	NULL	Recruiting	18 Years	80 Years	All	15	Phase 1/Phase 2	Israel

First Previous1Next Last